Ouweneel Dagmar M, Claessen Bimmer E, Sjauw Krischan D, Henriques José Ps
AMC Heartcenter, Academic Medical Center, Amsterdam, The Netherlands.
Interv Cardiol. 2015 Mar;10(1):39-44. doi: 10.15420/icr.2015.10.1.39.
The experience and usage of percutaneous cardiac assist devices in cardiogenic shock as well as high-risk percutaneous coronary intervention have increased over the years. Nonetheless, there is still little evidence of clinical benefit of these devices other than immediate haemodynamic improvement. Despite the fact that these devices are used to treat a rather complex patient population, clinical testing remains important in order to evaluate their true impact on clinical outcome before being adopted into clinical practice. Therefore, this review shows an overview of the current experience and evidence of the available percutaneous cardiac assist devices.
多年来，经皮心脏辅助装置在心源性休克以及高危经皮冠状动脉介入治疗中的应用经验不断增加。尽管如此，除了能立即改善血流动力学外，几乎没有证据表明这些装置具有临床益处。尽管这些装置用于治疗相当复杂的患者群体，但在被纳入临床实践之前，进行临床试验对于评估其对临床结局的真正影响仍然很重要。因此，本综述概述了当前可用经皮心脏辅助装置的经验和证据。
